Multilineage Cytotoxic Treatment for Advanced Colorectal Cancer inNonagenarians

Abstract

Decision making in older cancer patients is challenging. We present the case of a fit 90-year old patient with advanced colorectal cancer, focusing on the dilemmas we faced during multilineage systemic treatment. Although chemotherapy can be effective and tolerable in nonagenarians, current evidence on how to identify patients who will benefit from treatment is limited.